CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-24 | MILLIGAN JOHN F Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2020-08-24 | MILLIGAN JOHN F Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2020-08-24 | Hunkapiller Michael CEO & President | Sale | −259,164 | $6.63 | $1.7M | 1,162,830 |
| 2020-08-21 | Hunkapiller Michael CEO & President | Sale | −189,847 | $6.57 | $1.2M | 1,421,994 |
| 2020-08-20 | Hunkapiller Michael CEO & President | Sale | −256,554 | $6.47 | $1.7M | 1,611,841 |
| 2020-08-04 | Shapiro Lucy Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | ORDONEZ KATHY Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | MOHR MARSHALL Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | MILLIGAN JOHN F Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | LIVINGSTON RANDALL S Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | HENRY CHRISTIAN O Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | Ericson William W. Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-08-04 | Botstein David Director | Grant or award · Stock Option (right to buy) | +97,785 | 97,785 | ||
| 2020-03-24 | Phillips James Michael SVP, Research & Development | Sale | −2,760 | $3.05 | $8K | 249,220 |
| 2020-03-16 | HENRY CHRISTIAN O Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-03-16 | Hunkapiller Michael CEO & President | Grant or award | +150,000 | 2,548,215 | ||
| 2020-03-16 | Hunkapiller Michael CEO & President | Grant or award | +75,000 | 2,623,215 | ||
| 2020-02-20 | Phillips James Michael SVP, Research & Development | Sale | −5,050 | $4.48 | $23K | 251,980 |
| 2020-02-20 | Hunkapiller Michael Chairman, CEO & President | Sale | −166,575 | $4.50 | $750K | 1,868,395 |
| 2020-02-19 | BARNES SUSAN K EVP, CFO and PAO | Sale | −12,558 | $4.44 | $56K | 874,812 |
Page 20 of 29 · 561 trades